Press Releases by Category Health & Medicine
Subarachnoid Hemorrhage Market Detailed Industry Report Analysis 2025-2034
Introduction
Subarachnoid hemorrhage (SAH) is a severe neurological condition that occurs when bleeding takes place in the space between the brain and the thin tissues covering it. Although it represents a smaller fraction of stroke cases compared to ischemic strokes, it is associated with disproportionately higher morbidity and mortality rates. With lifestyle changes, rising incidence of brain aneurysms, and growing awareness of neurological health, the global demand for effective diagnostics, surgical…
United States Teleoncology Market Set for Transformative Growth with Expanding V …
Market Size and Growth:
The Global Teleoncology Market size reached US$ 4.70billion in 2024 and is expected to reach US$ 15.03 billion by 2032, growing at a CAGR of 15.7% during the forecast period 2025-2032.
The Teleoncology Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on…
Partial Seizure Market is expected to reach USD 13.4 billion by 2034
Partial seizures, also known as focal seizures, occur when abnormal electrical activity is confined to one area of the brain. They are among the most common forms of epilepsy, affecting millions globally, and can manifest as motor, sensory, or autonomic symptoms depending on the brain region involved. Partial seizures can remain localized or spread secondarily to generalized seizures.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72069
Management of partial seizures…
Primary Progressive Multiple Sclerosis (PPMS) Market is expected to reach USD 6. …
Primary progressive multiple sclerosis (PPMS) is a debilitating neurological disorder that represents approximately 10-15% of all multiple sclerosis (MS) cases. Unlike relapsing-remitting MS (RRMS), which is characterized by relapses followed by partial recovery, PPMS involves a steady progression of disability without distinct relapses. Symptoms include muscle weakness, gait difficulties, spasticity, fatigue, and cognitive decline, significantly impacting quality of life.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72071
Until recently, treatment…
Small Fiber Neuropathy Market is expected to reach USD 4.0 billion by 2034
Small fiber neuropathy (SFN) is a painful neurological disorder caused by damage to the small unmyelinated C fibers and thinly myelinated Aδ fibers of the peripheral nervous system. It manifests as burning pain, tingling, numbness, and autonomic dysfunction, often in the feet and hands. SFN is associated with conditions such as diabetes, autoimmune diseases, infections, genetic mutations, and chemotherapy-induced neuropathy.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72073
Despite its…
United States Lupus Nephritis Treatment Market 2025 | Growth Drivers, Key Player …
Market Size and Growth
Lupus Nephritis Treatment Market growing with a High CAGR during the forecast period 2024-2031.
Recent Mergers and Acquisitions & Key Development:
United States: Recent Industry Developments
✅ In September 2025, Biogen and UCB announced that their experimental lupus treatment, dapirolizumab pegol, successfully met the primary goal in a late-stage clinical trial, significantly reducing disease activity in patients with systemic lupus erythematosus.
✅ In May 2025, Kyverna Therapeutics reported $242.6 million in…
Spinal Muscular Atrophy (SMA) Market to Reach USD 13.1 Billion by 2034
Spinal muscular atrophy (SMA) is a rare genetic neuromuscular disorder caused by mutations in the SMN1 gene, leading to insufficient survival motor neuron (SMN) protein. This deficiency results in progressive muscle weakness, motor function loss, and in severe cases, respiratory failure. Affecting approximately 1 in 6,000-10,000 live births, SMA is one of the most common genetic causes of infant mortality.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72075
Over the…
United States Pharmacovigilance Software Market Report: Market Size, Trends, For …
Pharmacovigilance Software Market reached US$218.95 million in 2024 and is expected to reach US$415.42 million by 2033, growing at a CAGR of 7.4% during the forecast period of 2025-2033, according to DataM Intelligence research.
According to DataM Intelligence has released its latest research report on "Pharmacovigilance Software Market Size 2025," offering in-depth insights into key growth factors such as regional performance, market segmentation, CAGR trends, revenue analysis of leading players, and…
Tardive dyskinesia Market is expected to reach USD 8.2 billion by 2034
Tardive dyskinesia (TD) is a neurological movement disorder caused primarily by long-term use of dopamine receptor-blocking agents, such as antipsychotics and certain antiemetics. It is characterized by involuntary, repetitive movements of the face, tongue, and limbs, often irreversible and severely affecting quality of life. With the rising prevalence of psychiatric conditions such as schizophrenia, bipolar disorder, and major depressive disorder-and the increased use of antipsychotic medications-TD has emerged as a…
United States Ebola Vaccine Market Insights | Key Players, Regulatory Updates & …
Ebola Virus Vaccine Market reached US$173.82 million in 2024 and is expected to reach US$288.41 million by 2033, growing at a CAGR of 6.4% during the forecast period 2025-2033, according to DataM intelligence research.
According to DataM Intelligence has released its latest research report on "Ebola Virus Vaccine Market Size 2025," offering in-depth insights into key growth factors such as regional performance, market segmentation, CAGR trends, revenue analysis of leading players,…
United States Oncolytic Viral Therapy Market Set to Transform Cancer Treatment w …
Market Size and Growth:
The Oncolytic Viral Therapy Market size reached US$ 24.48 Million in 2024 and is expected to reach US$ 164.51 Million by 2033, growing at a CAGR of 23.8% during the forecast period 2025-2033.
The Oncolytic Viral Therapy Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market…
Transverse Myelitis Market is expected to reach USD 2.6 billion by 2034
Transverse myelitis (TM) is a rare neurological disorder caused by inflammation of the spinal cord, leading to motor, sensory, and autonomic dysfunction. Symptoms may include muscle weakness, paralysis, sensory disturbances, and bowel or bladder dysfunction. TM can occur as an isolated condition or be associated with autoimmune diseases such as multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), lupus, or infections.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72079
Despite…
United States AI-Enabled Medical Imaging Solutions Market Poised for Breakthroug …
Market Size and Growth:
The AI-Enabled Medical Imaging Solutions Market size reached US$ 10.63 Billion in 2024 and is expected to reach US$ 33.76 Billion by 2033, growing at a CAGR of 13.8% during the forecast period 2025-2033.
The AI-Enabled Medical Imaging Solutions Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations…
Dementia and Alzheimer's Disease Treatment Market Poised for Transformation with …
The Dementia and Alzheimers Disease Treatment market is estimated to be valued at USD 13.10 Bn in 2025 and is expected to reach USD 23.19 Bn by 2032, growing at a compound annual growth rate CAGR of 8.5% from 2025 to 2032.
➤ This report on the Dementia and Alzheimers Disease Treatment market offers an comprehensive analysis of the current trends, market size, and projections up to 2032. Combining qualitative and…
United States Neuropathic Pain Market Set for Strong Growth as Novel Therapies a …
Market Size and Growth:
The Neuropathic Pain Market size reached US$ 8.44 Billion in 2024 and is expected to reach US$ 18.45 Billion by 2033, growing at a CAGR of 8.9 % during the forecast period 2025-2033.
The Neuropathic Pain Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants…
The Diamond Rehab Thailand named best drug rehab in 2025 feature
The Diamond Rehab Thailand has been recognised as the top drug rehabilitation centre in a recent feature article published on the Newcastle Herald, highlighting leading treatment providers for 2025.
The piece ranked five standout facilities worldwide, assessing factors such as therapeutic quality, client experience, privacy and value for money. The Diamond Rehab Thailand earned the number one position for delivering Western-standard clinical care in a luxury setting, while offering significantly lower…
The global point-of-care diagnostics for Huntington's disease market is expected …
According to the report published by Virtue Market Research The global point-of-care diagnostics for Huntington's disease market was valued at USD 3.12 billion in 2024 and will grow at a CAGR of 4% from 2025 to 2030. The market is expected to reach USD 3.95 billion by 2030.
Request Sample Copy of this Report @https://virtuemarketresearch.com/report/point-of-care-diagnostics-market/request-sample
The global point of care diagnostics for Huntington disease market is becoming an important part of healthcare.…
ITO Target Market Segmentation Analysis by Application, Type, and Key Players-, …
New Jersey, US State: "The global ITO Target market in the Information Technology and Telecom category is projected to reach USD 4.7 billion by 2031, growing at a CAGR of 8.3% from 2025 to 2031. With rising industrial adoption and continuous innovation in Information Technology and Telecom applications, the market is estimated to hit USD 2.5 billion in 2024, highlighting strong growth potential throughout the forecast period."
ITO Target Market Size…
Hereditary Testing Market Fueled by Evolving Trends and Strategic Growth, Featur …
The Hereditary Testing market is estimated to be valued at USD 7.81 Bn in 2025 and is expected to reach USD 13.84 Bn by 2032, growing at a compound annual growth rate CAGR of 8.5% from 2025 to 2032.
➤ The latest Report on the Hereditary Testing Research (2025-2032) offers an in-depth analysis of market size, share, drivers, restraints, etc. Furthermore, this report includes a rough study of different segments in…
Patient Support Programs Market Set to Significantly Grow from 2025 to 2032 | Ro …
The Patient Support Programs (PSP) market is estimated to be valued at USD 22.70 Bn in 2025 and is expected to reach USD 68.95 Bn by 2032, growing at a compound annual growth rate CAGR of 17.2% from 2025 to 2032.
➤ The Patient Support Programs (PSP) Market is thoroughly analysed by Coherent Market Insights, providing readers with a comprehensive exploration from various angles. This examination grants readers access to a…
Inhalation Capsules Market Poised for Strategic Growth Amidst Innovations from G …
The Inhalation Capsules market is estimated to be valued at USD 980.1 Mn in 2025 and is expected to reach USD 1,524.4 Mn by 2032, growing at a compound annual growth rate CAGR of 6.5% from 2025 to 2032.
➤ The latest report titled Inhalation Capsules Market Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032. offering a comprehensive and in-depth analysis of the industry. The report provides key insights into current…
Tropical Spastic Paraparesis Market to Reach USD 1.3 Billion by 2034
Tropical spastic paraparesis (TSP), also known as HTLV-1-associated myelopathy (HAM/TSP), is a chronic, progressive neurological disorder caused by infection with the human T-cell lymphotropic virus type 1 (HTLV-1). The condition is most prevalent in parts of Africa, the Caribbean, South America, Japan, and the Middle East, with patients experiencing progressive weakness, stiffness, sensory disturbances, and bladder dysfunction due to spinal cord inflammation.
Download Full PDF Sample Copy of Market Report @…
Bipolar Disorder (Manic Depression) Market to Reach USD 14.8 Billion by 2034
Bipolar disorder, also known as manic depression, is a chronic psychiatric condition characterized by extreme mood swings, ranging from manic or hypomanic episodes to depressive phases. It affects an estimated 40-45 million people worldwide, significantly impacting quality of life, social functioning, and productivity.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72083
Traditionally managed with mood stabilizers (lithium, valproate), antipsychotics, and antidepressants, treatment has evolved with the introduction of atypical antipsychotics,…
Postoperative Pain Market is expected to reach USD 58.9 billion by 2034
Postoperative pain is one of the most common and challenging complications following surgery. Effective pain control is crucial for patient recovery, reduced hospital stays, and prevention of chronic pain syndromes. Globally, more than 300 million surgeries are performed annually, and the increasing prevalence of chronic diseases, trauma, orthopedic conditions, and cancer has driven surgical demand.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72085
Traditionally, pain has been managed with opioids,…
United States Nucleic Acid Therapeutics Market Set for Breakthrough Growth with …
Market Size and Growth:
The Global Nucleic Acid Therapeutics Market size reached US$ 5.64 billion in 2024 and is expected to reach US$ 14.42 billion by 2032, growing at a CAGR of 10.9% during the forecast period 2025-2032.
The Nucleic Acid Therapeutics Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for…
Dravet Syndrome (DS) market is expected to reach USD 1.9 billion by 2034
Dravet syndrome (DS) is a rare, severe, and lifelong form of epilepsy that typically begins in infancy. Characterized by prolonged seizures, developmental delays, motor impairments, and increased mortality risk, DS is caused primarily by mutations in the SCN1A gene. With an estimated incidence of 1 in 15,000-20,000 live births, DS is a rare but devastating condition that significantly impacts patients and families.
Download Full PDF Sample Copy of Market Report @…
Generalized Myasthenia Gravis (gMG) Market is expected to reach $9.8 billion by …
Generalized myasthenia gravis (gMG) is a rare, chronic autoimmune neuromuscular disorder characterized by muscle weakness, fatigue, and impaired communication between nerves and muscles. It is caused by autoantibodies-primarily against acetylcholine receptors (AChR) or muscle-specific kinase (MuSK)-that disrupt neuromuscular transmission. gMG significantly impacts patients' quality of life, often leading to difficulties in mobility, vision, swallowing, and breathing.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72089
Historically, treatment revolved around acetylcholinesterase inhibitors…
Lennox-Gastaut Syndrome (LGS) market is expected to reach USD 3.9 billion by 203 …
Lennox-Gastaut syndrome (LGS) is a severe, rare, childhood-onset epilepsy characterized by multiple seizure types, cognitive impairment, and resistance to standard antiepileptic drugs (AEDs). It accounts for 2-5% of childhood epilepsies and significantly impacts quality of life due to frequent, treatment-resistant seizures and developmental delays.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72091
Historically, LGS treatment relied on polytherapy with limited effectiveness, using AEDs such as valproate, lamotrigine, and topiramate, along…
Neuromyelitis Optica Spectrum Disorder (NMOSD) Market to Reach USD 5.6 Billion b …
Neuromyelitis optica spectrum disorder (NMOSD) is a rare, chronic autoimmune disorder of the central nervous system primarily affecting the optic nerves and spinal cord, leading to vision loss, paralysis, and life-threatening relapses. Once misdiagnosed as multiple sclerosis (MS), NMOSD is now recognized as a distinct disease, largely associated with aquaporin-4 (AQP4) antibodies or, in some cases, myelin oligodendrocyte glycoprotein (MOG) antibodies.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72093
For…
Spinocerebellar Ataxia (SCA) Market to Reach USD 2.1 Billion by 2034
Spinocerebellar ataxia (SCA) refers to a group of rare, inherited neurodegenerative disorders characterized by progressive loss of coordination, balance, and motor control due to cerebellar and spinal cord dysfunction. With more than 40 genetic subtypes identified (SCA1-SCA48), these disorders are typically autosomal dominant and present in adolescence or adulthood. Symptoms worsen over time, leading to gait instability, slurred speech, tremors, and, in advanced cases, severe disability.
Download Full PDF Sample Copy…
United States COVID-19 Vaccine Market Set for Transformative Growth Driven by In …
Market Size and Growth:
The Global COVID-19 Vaccine Market size reached US$ 13.43 billion in 2024 and is expected to reach US$ 29.98 billion by 2033, growing at a CAGR of 9.8% during the forecast period 2025-2033.
The COVID-19 Vaccine Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants…
Alzheimer's Disease Market is expected to reach USD 17.2 billion by 2034
Alzheimer's disease (AD) is the most common cause of dementia, accounting for 60-70% of cases worldwide. It is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, behavioral changes, and loss of independence. With aging populations, especially in developed and emerging economies, Alzheimer's is becoming a global healthcare challenge, placing enormous economic and emotional burdens on patients, families, and healthcare systems.
Download Full PDF Sample Copy of Market Report @…
Bronchopulmonary Dysplasia (BPD) Patient Pool Analysis and Market Forecast 2024- …
Introduction
Bronchopulmonary dysplasia (BPD) is a chronic lung disease that primarily affects premature infants requiring prolonged mechanical ventilation or supplemental oxygen. It remains one of the most serious complications of preterm birth, with lasting effects on pulmonary function, growth, and neurodevelopment.
The condition not only drives neonatal intensive care unit (NICU) costs but also increases long-term healthcare utilization for affected children. Growing global rates of preterm birth, along with improvements in neonatal…
Dementia with Lewy Bodies (DLB) Market is expected to reach 6.8 million by 2034
Dementia with Lewy bodies (DLB) is the second most common form of progressive dementia after Alzheimer's disease, accounting for 10-15% of dementia cases worldwide. It is characterized by the abnormal buildup of alpha-synuclein proteins (Lewy bodies) in the brain, leading to cognitive decline, fluctuations in alertness, Parkinsonian motor symptoms, sleep disturbances, and hallucinations.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72099
The complexity of DLB often leads to underdiagnosis or…
United States Esophageal Cancer Treatment Market Set for Breakthrough Growth wit …
Market Overview:
The Global Esophageal Cancer Treatment Market size reached US$ 1.31 billion in 2024 and is expected to reach US$ 2.66 billion by 2033, growing at a CAGR of 8.2% during the forecast period 2025-2033.
The Esophageal Cancer Treatment Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants…
Imaging CRO Market to Reflect Significant Incremental Opportunity from 2025 to 2 …
The Imaging CRO market is estimated to be valued at USD 5.61 Bn in 2025 and is expected to reach USD 9.68 Bn by 2032, growing at a compound annual growth rate CAGR of 8.1% from 2025 to 2032.
➤ Coherent Market Insights has published an in-depth research report titled "Imaging CRO Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032." This study offers a deep dive into the Imaging…
Epilepsy Patient Pool Analysis Market to Reach 92 Million Patients by 2034
Epilepsy is one of the most common chronic neurological disorders, affecting more than 65 million people worldwide. Characterized by recurrent, unprovoked seizures due to abnormal brain activity, epilepsy significantly impacts patients' quality of life and creates social, educational, and economic challenges. While the condition affects all ages, it is especially common among children and elderly populations, where diagnosis and management can be particularly complex.
Download Full PDF Sample Copy of Market…
Social Security Trust Fund Depletion Accelerated to 2032-2034: A Breakdown of th …
Social Security depletion accelerated to 2032-34. Recent laws may trigger 20% benefit cuts for 69M Americans. $2,000 benefits right $1,600. Expert: '$25 trillion deficit solvable but time running out.' Analysis reveals how well-intentioned legislation inadvertently accelerated the crisis timeline.
Toms River, NJ - A new analysis [https://medium.com/@press_52522/social-securitys-2025-trustees-report-what-retirees-need-to-know-2a6e8af501f0] of the 2025 Social Security Board of Trustees report shows recent legislative action has sped up the date of the trust fund depletion to…
Point-of-Care Ultrasound System Market: is Going to Boom: Strategic Insights and …
The Point-of-care Ultrasound System market is estimated to be valued at USD 5.71 Bn in 2025 and is expected to reach USD 7.77 Bn by 2032, growing at a compound annual growth rate CAGR of 4.5% from 2025 to 2032.
➤ This report on the Point-of-care Ultrasound System market offers an comprehensive analysis of the current trends, market size, and projections up to 2032. Combining qualitative and quantitative insights, the report…
Acute Ischemic Stroke (AIS) Market is expected to reach USD 17.5 billion by 2034
Acute ischemic stroke (AIS) is a life-threatening neurological emergency caused by the obstruction of blood flow to the brain, accounting for nearly 85% of all stroke cases worldwide. Stroke remains a leading cause of death and long-term disability, affecting millions annually and placing an immense burden on healthcare systems.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72103
Over the past two decades, treatment has advanced significantly with intravenous thrombolysis (IV…
Removable Partial Denture Market to Witness Growth and Offer Comprehensive Busin …
The Removable Partial Denture market is estimated to be valued at USD 1.06 Bn in 2025 and is expected to reach USD 1.43 Bn by 2032, growing at a compound annual growth rate CAGR of 4.3% from 2025 to 2032.
➤ The qualitative latest Research report (2025-2032) on the Removable Partial Denture Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape.…
Brain Implants Market to Reach USD 13.6 Billion by 2034
Brain implants, also known as neuroprosthetics or neural implants, are medical devices placed directly into the brain to restore or enhance neurological function. These implants play a critical role in the management of neurological disorders, sensory impairments, movement disorders, and cognitive deficits, while also being explored for human-machine interface applications.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72105
From deep brain stimulation (DBS) for Parkinson's disease and epilepsy, to cochlear…
United States External & Implantable Cardiac Defibrillators Market Set for Stron …
Market Size and Growth:
The Global External and Implantable Cardiac Defibrillators Market size reached US$ 6.58 billion in 2024 and is expected to reach US$ 12.16 billion by 2033, growing at a CAGR of 7.1% during the forecast period 2025-2033.
The External and Implantable Cardiac Defibrillators Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market…
Cerebrospinal Fluid (CSF) Management Market is expected to reach USD 3.3 billion …
Cerebrospinal fluid (CSF) plays a vital role in protecting the brain and spinal cord, regulating intracranial pressure, and maintaining central nervous system homeostasis. Disorders such as hydrocephalus, traumatic brain injury, intracranial hypertension, and central nervous system infections often require medical or surgical management of CSF to relieve pressure and prevent neurological damage.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72107
The CSF management market has been traditionally dominated by shunt systems…
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview:
The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical…
Flow Diverters Market is expected to reach USD 3.5 billion by 2034
Flow diverters are specialized endovascular stents designed to treat intracranial aneurysms, particularly wide-neck and large or giant aneurysms that are difficult to manage with traditional coiling or clipping. By redirecting blood flow away from the aneurysm sac, these devices promote endothelial remodeling and vessel healing, reducing the risk of rupture.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72109
Over the past decade, flow diverters have transformed neurointerventional care, with products…
Tablet Coatings Market Set to Witness Significant Growth from 2025 to 2032 Featu …
The Tablet Coatings market is estimated to be valued at USD 958.9 Mn in 2025 and is expected to reach USD 1,413.1 Mn by 2032, growing at a compound annual growth rate CAGR of 5.7% from 2025 to 2032.
➤ The latest report from Coherent Market Insights examines the growth prospects of the Tablet Coatings Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key…
Intracranial Pressure (ICP) Monitoring Devices Market is expected to reach USD 3 …
Intracranial pressure (ICP) monitoring is a critical component in the management of patients with traumatic brain injury (TBI), intracerebral hemorrhage, hydrocephalus, stroke, brain tumors, and central nervous system (CNS) infections. Elevated ICP can cause severe brain damage or death, making timely monitoring essential for guiding treatment decisions and improving outcomes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72111
Traditionally, invasive catheter-based devices have dominated the market, but recent advances in…
Klotho Skin Announces Partnership with Leonhardt Ventures
Innovative longevity-based skincare now available through leading platform for purpose-driven brands
Los Angeles, CA - September 18, 2025 - Klotho Skin, a pioneer in genetics-based skincare, is proud to announce that its products are now available on Leonhardt Ventures, a platform dedicated to supporting innovative and mission-driven companies.
Known for its groundbreaking work with the Klotho gene, a key regulator of aging, Klotho Skin offers the first skincare line designed to work…
Sapphire FUE Hair Transplant: Achieve Natural-Looking Hair with Advanced Technol …
Sapphire FUE Hair Transplant: Achieve Natural-Looking Hair with Advanced Technology
The Evolution of Hair Transplantation: Introducing Sapphire FUE
Hair loss is a widespread concern, but advancements in hair transplantation techniques offer increasingly refined solutions. The Sapphire FUE Hair Transplant technique stands out by delivering highly natural and aesthetic results. Unlike traditional FUE, it employs blades made from sapphire, allowing for finer incisions.
Precision and Minimized Trauma
These precise micro-channels lead to quicker healing and…
Go To Page 11318 11317 11316 11315 11314 11313 11312 11311 11310 11309 10988 10987 10986 10985 10984 10983 10982 10981 10980 10979
